Page last updated: 2024-11-12

7-methoxycryptopleurine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7-methoxycryptopleurine: has anti-inflammatory activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11848155
CHEMBL ID2180704
SCHEMBL ID13222745
MeSH IDM0508732

Synonyms (4)

Synonym
7-methoxycryptopleurine
CHEMBL2180704
SCHEMBL13222745
2,3,6,7-tetramethoxy-11,12,13,14,14a,15-hexahydro-9h-phenanthro[9,10-b]quinolizine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID710994Growth inhibition of human NUGC3 cells2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
AID710975Solubility in DMSO2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
AID710957Oral bioavailability in Sprague-Dawley rat at 3 mg/kg by HPLC-MS method2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
AID710993Growth inhibition of human HONE1 cells2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
AID710974Solubility in DMA2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
AID710995Growth inhibition of human SF268 cells2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
AID710997Growth inhibition of human MCF7 cells2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
AID710996Growth inhibition of human NCI-H460 cells2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
AID710992Antiviral activity against Transmissible gastroenteritis virus infected in ST cells pre-treated 2 hrs before virus infection measured 6 hrs post virus infection by immunofluorescent assay2012Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23
Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: exploration of the role of tylophorine e ring on biological activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.75 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]